Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa
- 1 August 1995
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 4 (4) , 199-206
- https://doi.org/10.1111/j.1600-0625.1995.tb00245.x
Abstract
Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal form of junctional epidermolysis bullosa characterized by generalized skin and mucosal blisters that heal with atrophy; other features include alopecia, nail dystrophy, large melanocytic nevi, and autosomal recessive inheritance. The specific aim of this study was to identify an abnormality in epidermal basement membrane adhesion molecules in well characterized GABEB patients that would explain why these subjects' epidermis separates from their epidermal basement membrane. Cryostat sections of nonlesional skin from 8 GABEB patients in 5 different families as well as skin from normal volunteers (controls) were studied by indirect immunofluorescence microscopy using rabbit antiserum directed against a BPAG1 fusion protein or monoclonal antibodies directed against the extracellular domain of BPAG2 (HD18 and 233), epiligrin (P1E1), laminin 5 (GB3), types IV and VII collagen, or integrin subunits alpha 2, alpha 3, beta 1, alpha 6, or beta 4. In these studies, monoclonal antibodies HD18 and 233 showed no reactivity and diminished reactivity, respectively, to the epidermal BM of all GABEB patients. Interestingly, in one patient, the absent or diminished reactivities of monoclonal anti-BPAG2 antibodies were limited to well demarcated portions of an otherwise intact epidermal basement membrane. Moreover, BPAG1, epiligrin, laminin 5, types IV and VII collagen, and all integrin subunits under study were expressed in the same manner in both GABEB and normal human skin. These findings identify an abnormality in the extracellular domain of BPAG2 in the skin of GABEB patients. BPAG2 (type XVII collagen) is a transmembrane, hemidesmosome-associated molecule whose extracellular domain resides at the exact level where blisters develop in the skin of patients with GABEB.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 37 references indexed in Scilit:
- Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosaNature Genetics, 1994
- The molecular genetics of dystrophic epidermolysis bullosaArchives of Dermatology, 1993
- Nicein (BM-600) in Junctional Epidermolysis Bullosa: Polyclonal Antibodies Provide New Clues for Pathogenic RoleJournal of Investigative Dermatology, 1993
- Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patientsExperimental Dermatology, 1992
- Expression of Integrin α6β4 in Junctional Epidermolysis BullosaJournal of Investigative Dermatology, 1992
- Molecular genetics of epidermolysis bullosaScience, 1992
- Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skinJournal of the American Academy of Dermatology, 1991
- Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosaJournal of the American Academy of Dermatology, 1991
- Production of Rabbit Antibodies Against Carboxy-Terminal Epitopes Encoded by Bullous Pemphigoid cDNAJournal of Investigative Dermatology, 1990